Search research articles
Contact Us
Filters
Showing results (201-210 of 245) with videos related to
Page
of 25
Sort By:
Gastroenterology
|
May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevir
Fred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 20, 2015
Discovery, design, and synthesis of indole-based EZH2 inhibitors
Victor S Gehling, Rishi G Vaswani, Christopher G Nasveschuk, et al.
Lancet (London, England)
|
August 10, 2010
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Paul Y Kwo, Eric J Lawitz, Jonathan McCone, et al.
Zeitschrift Fur Rheumatologie
|
October 15, 2021
[Development of quality standards for patients with rheumatoid arthritis for use in Germany]
U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
ACS Medicinal Chemistry Letters
|
June 20, 2020
Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors
Victor S Gehling, John P McGrath, Martin Duplessis, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 2, 2016
Identification of potent, selective KDM5 inhibitors
Victor S Gehling, Steven F Bellon, Jean-Christophe Harmange, et al.
Zeitschrift Fur Rheumatologie
|
August 11, 2021
[Development of quality standards for patients with axial spondyloarthritis for use in Germany]
U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Journal of Medicinal Chemistry
|
February 21, 2015
Discovery of potent and selective 8-fluorotriazolopyridine c-Met inhibitors
Emily A Peterson, Yohannes Teffera, Brian K Albrecht, et al.
Journal of Medicinal Chemistry
|
April 23, 2015
Correction to Discovery of Potent and Selective 8-Fluorotriazolopyridine c-Met Inhibitors
Emily A Peterson, Yohannes Teffera, Brian K Albrecht, et al.
Digestive Diseases and Sciences
|
May 1, 2012
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection
Paul J Clark, Alexander J Thompson, Qianqian Zhu, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 245) with videos related to
Sort By:
Page
of 25
Gastroenterology
|
May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevir
Fred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 20, 2015
Discovery, design, and synthesis of indole-based EZH2 inhibitors
Victor S Gehling, Rishi G Vaswani, Christopher G Nasveschuk, et al.
Lancet (London, England)
|
August 10, 2010
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Paul Y Kwo, Eric J Lawitz, Jonathan McCone, et al.
Zeitschrift Fur Rheumatologie
|
October 15, 2021
[Development of quality standards for patients with rheumatoid arthritis for use in Germany]
U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
ACS Medicinal Chemistry Letters
|
June 20, 2020
Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors
Victor S Gehling, John P McGrath, Martin Duplessis, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 2, 2016
Identification of potent, selective KDM5 inhibitors
Victor S Gehling, Steven F Bellon, Jean-Christophe Harmange, et al.
Zeitschrift Fur Rheumatologie
|
August 11, 2021
[Development of quality standards for patients with axial spondyloarthritis for use in Germany]
U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Journal of Medicinal Chemistry
|
February 21, 2015
Discovery of potent and selective 8-fluorotriazolopyridine c-Met inhibitors
Emily A Peterson, Yohannes Teffera, Brian K Albrecht, et al.
Journal of Medicinal Chemistry
|
April 23, 2015
Correction to Discovery of Potent and Selective 8-Fluorotriazolopyridine c-Met Inhibitors
Emily A Peterson, Yohannes Teffera, Brian K Albrecht, et al.
Digestive Diseases and Sciences
|
May 1, 2012
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection
Paul J Clark, Alexander J Thompson, Qianqian Zhu, et al.
Page
of 25